TY - JOUR AU - Shojaei, F. PY - 2012 DA - 2012// TI - Anti-angiogenesis therapy in cancer: current challenges and future perspectives JO - Cancer Lett VL - 320 UR - https://doi.org/10.1016/j.canlet.2012.03.008 DO - 10.1016/j.canlet.2012.03.008 ID - Shojaei2012 ER - TY - JOUR AU - Sandler, A. AU - Gray, R. AU - Perry, M. C. AU - Brahmer, J. AU - Schiller, J. H. AU - Dowlati, A. AU - Lilenbaum, R. AU - Johnson, D. H. PY - 2006 DA - 2006// TI - Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer JO - N Engl J Med VL - 355 UR - https://doi.org/10.1056/NEJMoa061884 DO - 10.1056/NEJMoa061884 ID - Sandler2006 ER - TY - JOUR AU - Zondor, S. D. AU - Medina, P. J. PY - 2004 DA - 2004// TI - Bevacizumab: an angiogenesis inhibitor with efficacy in colorectal and other malignancies JO - Ann Pharmacother VL - 38 UR - https://doi.org/10.1345/aph.1D470 DO - 10.1345/aph.1D470 ID - Zondor2004 ER - TY - JOUR AU - Sun, L. AU - Liang, C. AU - Shirazian, S. AU - Zhou, Y. AU - Miller, T. AU - Cui, J. AU - Fukuda, J. Y. AU - Chu, J. Y. AU - Nematalla, A. AU - Wang, X. PY - 2003 DA - 2003// TI - Discovery of 5-[5-fluoro-2-oxo-1,2- dihydroindol-(3Z)-ylidenemethyl]-2,4- dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide, a novel tyrosine kinase inhibitor targeting vascular endothelial and platelet-derived growth factor receptor tyrosine kinase JO - J Med Chem VL - 46 UR - https://doi.org/10.1021/jm0204183 DO - 10.1021/jm0204183 ID - Sun2003 ER - TY - JOUR AU - Faivre, S. AU - Demetri, G. AU - Sargent, W. AU - Raymond, E. PY - 2007 DA - 2007// TI - Molecular basis for sunitinib efficacy and future clinical development JO - Nat Rev Drug Discov VL - 6 UR - https://doi.org/10.1038/nrd2380 DO - 10.1038/nrd2380 ID - Faivre2007 ER - TY - JOUR AU - Goodman, V. L. AU - Rock, E. P. AU - Dagher, R. AU - Ramchandani, R. P. AU - Abraham, S. AU - Gobburu, J. V. AU - Booth, B. P. AU - Verbois, S. L. AU - Morse, D. E. AU - Liang, C. Y. PY - 2007 DA - 2007// TI - Approval summary: sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-06-2328 DO - 10.1158/1078-0432.CCR-06-2328 ID - Goodman2007 ER - TY - JOUR AU - Rugo, H. S. AU - Herbst, R. S. AU - Liu, G. AU - Park, J. W. AU - Kies, M. S. AU - Steinfeldt, H. M. AU - Pithavala, Y. K. AU - Reich, S. D. AU - Freddo, J. L. AU - Wilding, G. PY - 2005 DA - 2005// TI - Phase I trial of the oral antiangiogenesis agent AG-013736 in patients with advanced solid tumors: pharmacokinetic and clinical results JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.04.192 DO - 10.1200/JCO.2005.04.192 ID - Rugo2005 ER - TY - JOUR AU - Hu-Lowe, D. D. AU - Zou, H. Y. AU - Grazzini, M. L. AU - Hallin, M. E. AU - Wickman, G. R. AU - Amundson, K. AU - Chen, J. H. AU - Rewolinski, D. A. AU - Yamazaki, S. AU - Wu, E. Y. PY - 2008 DA - 2008// TI - Nonclinical antiangiogenesis and antitumor activities of axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1, 2, 3 JO - Clin Cancer Res VL - 14 UR - https://doi.org/10.1158/1078-0432.CCR-08-0652 DO - 10.1158/1078-0432.CCR-08-0652 ID - Hu-Lowe2008 ER - TY - CHAP AU - Marrone TJ, H. -. L. D. AU - Grazzini, M. AU - Yin, M. J. AU - Chen, J. AU - Hallin, M. PY - 2007 DA - 2007// TI - PF-00337210, a potent, selective and orally bioavailable small molecule inhibitor of VEGFR-2 BT - Proceedings of the 98th Annual Meeting of the American Association for Cancer Research; AACR Meeting Abstracts: 2007 PB - AACR CY - Los Angeles, CA ID - Marrone TJ2007 ER - TY - JOUR AU - Liu PY - 2009 DA - 2009// TI - Phase I pharmacokinetic (PK) and pharmacodynamic (PD) study of PF-00337210, a highly selective VEGFR inhibitor JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.20.6664 DO - 10.1200/JCO.2008.20.6664 ID - Liu2009 ER - TY - JOUR AU - Chang, E. H. AU - Gonda, M. A. AU - Ellis, R. W. AU - Scolnick, E. M. AU - Lowy, D. R. PY - 1982 DA - 1982// TI - Human genome contains four genes homologous to transforming genes of Harvey and Kirsten murine sarcoma viruses JO - Proc Natl Acad Sci U S A VL - 79 UR - https://doi.org/10.1073/pnas.79.16.4848 DO - 10.1073/pnas.79.16.4848 ID - Chang1982 ER - TY - JOUR AU - Riely, G. J. AU - Marks, J. AU - Pao, W. PY - 2009 DA - 2009// TI - KRAS mutations in non-small cell lung cancer JO - Proc Am Thorac Soc VL - 6 UR - https://doi.org/10.1513/pats.200809-107LC DO - 10.1513/pats.200809-107LC ID - Riely2009 ER - TY - JOUR AU - Hingorani, S. R. AU - Petricoin, E. F. AU - Maitra, A. AU - Rajapakse, V. AU - King, C. AU - Jacobetz, M. A. AU - Ross, S. AU - Conrads, T. P. AU - Veenstra, T. D. AU - Hitt, B. A. PY - 2003 DA - 2003// TI - Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse JO - Cancer Cell VL - 4 UR - https://doi.org/10.1016/S1535-6108(03)00309-X DO - 10.1016/S1535-6108(03)00309-X ID - Hingorani2003 ER - TY - JOUR AU - Aguirre, A. J. AU - Bardeesy, N. AU - Sinha, M. AU - Lopez, L. AU - Tuveson, D. A. AU - Horner, J. AU - Redston, M. S. AU - DePinho, R. A. PY - 2003 DA - 2003// TI - Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma JO - Genes Dev VL - 17 UR - https://doi.org/10.1101/gad.1158703 DO - 10.1101/gad.1158703 ID - Aguirre2003 ER - TY - JOUR AU - Simmons, B. H. AU - Lee, J. H. AU - Lalwani, K. AU - Giddabasappa, A. AU - Snider, B. A. AU - Wong, A. AU - Lappin, P. B. AU - Eswaraka, J. AU - Kan, J. L. AU - Christensen, J. G. PY - 2012 DA - 2012// TI - Combination of a MEK inhibitor at sub-MTD with a PI3K/mTOR inhibitor significantly suppresses growth of lung adenocarcinoma tumors in Kras(G12D-LSL) mice JO - Cancer Chemother Pharmacol VL - 70 UR - https://doi.org/10.1007/s00280-012-1899-6 DO - 10.1007/s00280-012-1899-6 ID - Simmons2012 ER - TY - JOUR AU - Pollock, L. AU - Rampling, D. AU - Greenwald, S. E. AU - Malone, M. PY - 1995 DA - 1995// TI - Desmin expression in rhabdomyosarcoma: influence of the desmin clone and immunohistochemical method JO - J Clin Pathol VL - 48 UR - https://doi.org/10.1136/jcp.48.6.535 DO - 10.1136/jcp.48.6.535 ID - Pollock1995 ER - TY - JOUR AU - Roybal, J. D. AU - Zang, Y. AU - Ahn, Y. H. AU - Yang, Y. AU - Gibbons, D. L. AU - Baird, B. N. AU - Alvarez, C. AU - Thilaganathan, N. AU - Liu, D. D. AU - Saintigny, P. PY - 2011 DA - 2011// TI - miR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1 JO - Mol Canc Res VL - 9 UR - https://doi.org/10.1158/1541-7786.MCR-10-0497 DO - 10.1158/1541-7786.MCR-10-0497 ID - Roybal2011 ER - TY - JOUR AU - Chen, J. J. AU - Lin, Y. C. AU - Yao, P. L. AU - Yuan, A. AU - Chen, H. Y. AU - Shun, C. T. AU - Tsai, M. F. AU - Chen, C. H. AU - Yang, P. C. PY - 2005 DA - 2005// TI - Tumor-associated macrophages: the double-edged sword in cancer progression JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.12.172 DO - 10.1200/JCO.2005.12.172 ID - Chen2005 ER - TY - JOUR AU - Planchard, D. PY - 2011 DA - 2011// TI - Bevacizumab in non-small-cell lung cancer: a review JO - Expert Rev Anticancer Ther VL - 11 UR - https://doi.org/10.1586/era.11.80 DO - 10.1586/era.11.80 ID - Planchard2011 ER - TY - JOUR AU - Faivre, S. AU - Delbaldo, C. AU - Vera, K. AU - Robert, C. AU - Lozahic, S. AU - Lassau, N. AU - Bello, C. AU - Deprimo, S. AU - Brega, N. AU - Massimini, G. PY - 2006 DA - 2006// TI - Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2005.02.2194 DO - 10.1200/JCO.2005.02.2194 ID - Faivre2006 ER - TY - JOUR AU - Allavena, P. AU - Mantovani, A. PY - 2012 DA - 2012// TI - Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment JO - Clin Exp Immunol VL - 167 UR - https://doi.org/10.1111/j.1365-2249.2011.04515.x DO - 10.1111/j.1365-2249.2011.04515.x ID - Allavena2012 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/13/213/prepub UR - http://www.biomedcentral.com/1471-2407/13/213/prepub ID - ref22 ER -